Deutsche Bank analyst Emmanuel Papadakis downgraded GSK (GSK) to Hold from Buy with a price target of 1,350 GBp, down from 1,700 GBp.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GSK:
- Vaccine makers fall after Trump nominates RFK to head HHS
- Trump names Robert Kennedy as Secretary of Health and Human Services
- GSK announces Blenrep met key secondary endpoint in DREAMM-7 trial
- Reporters tweets about ‘vague whispers’ of bid interest in TG Therapeutics
- GSK downgraded to Hold from Buy at Jefferies